June 5, 2023 News by Marisa Wexler, MS Analyses of protein levels in blood can help ID MS patient subgroups Analyses of protein levels in the blood can be used to identify groups of multiple sclerosis (MS) patients with distinct clinical features, new research shows. Given the variability of symptoms among people with MS, such groupings could help to improve individualized care for patients, according to Octave, a…
August 11, 2021 News by Forest Ray PhD Nurse With MS Wins Grant to Find Severity, Progression Biomarkers A nurse and PhD candidate with multiple sclerosis (MS) is looking for disease biomarkers that can help healthcare providers better estimate how individual cases of MS will progress. The goal of Stephanie Buxhoeveden’s research, now supported by a grant from the American Association of Nurse Practitioners (AANP), is…
February 19, 2020 Columns by Stephanie Towler I’ve Been Spoiled by My Clinical Trial The new year brings many changes, including the last year of my clinical trial. When I think about the past seven years, I am thankful for the opportunity to join the trial when I did and receive personal care that made fighting MS easier. It may sound crazy, but…
April 29, 2019 Columns by Ed Tobias MS News that Caught My Eye Last Week: Tai Chi Study, Lemtrada Safety Review, Personalized Treatment, Online Depression Therapy Study Will Explore Benefits of Tai Chi, Meditation on MS Patientsā Balance I’ve tried yoga to help with my balance and flexibility and found it useful. But tai chi scares me a little ā it seems too difficult. Maybe, if the results of this study are very positive, I’ll…
April 4, 2017 News by Patricia Silva, PhD Research on Faulty Stem Cells Suggests MS Patients Need Tailored Therapies Brain stem cells from primary progressive multiple sclerosis (PPMS) patients lack the ability to repair brain damage and to trigger the maturation of protective myelin-producing cells, a surprising study with far-reaching implications indicates. The study also showed that stem cells from individual patients reacted differently to compounds developed to trigger…
March 18, 2016 News by Patricia Silva, PhD Blood Biomarkers of Multiple Sclerosis May Predict a Person’s Response to Treatment Blood biomarkers in individual multiple sclerosisĀ patientsĀ mayĀ help clinicians determine which treatments would be ofĀ mostĀ benefit to that person, according to researchersĀ atĀ Oklahoma Medical Research FoundationĀ (OMRF). The study, published in the journalĀ Neurology, Neuroimmunology & Neuroinflammation, isĀ titled “Cytokine profiles show heterogeneity of interferon-Ī² response in multiple sclerosis patients.”…